Japan vascular access devices market is projected to witness a CAGR of 6.14% during the forecast period FY2026-FY2033, growing from USD 388.44 million in FY2025 to USD 589.42 million in FY2033. Japan market for dermal fillers has grown significantly due to rising prevalence of chronic conditions such as cancer and renal disease is prompting increased use of vascular access devices across Japanese healthcare settings. Government healthcare reforms and hospital infrastructure upgrades are further facilitating the adoption of advanced vascular technologies. Additionally, local manufacturers’ focus on safety-engineered, infection-resistant catheters is accelerating market growth in both acute and long-term care environments.
| Report Attribute | Details |
| Base Year | FY2025 |
| Forecast Period | FY2026-FY2033F |
| Historical Period | FY2019-FY2024 |
| Projected Growth Rate | CAGR of 6.14% between FY2025 and FY2033 |
| Revenue Forecast in FY2033 | USD 589.42 million |
For example, the Japanese Ministry of Health, Labor and Welfare (MHLW) approved the ClotTriever Thrombectomy System for DVT for national reimbursement on December 1, 2024, according to a statement released today by Inari Medical, Inc., a medical device company dedicated to treating and improving the lives of patients with venous and other vascular diseases. This statement comes after the Pharmaceuticals and Medical Devices Agency (PMDA) approved the ClotTriever system in December 2023. MHLW established a new functional category distinct from previous catheter-based therapies because of ClotTriever’s special mode of action for total, wall-to-wall thrombus elimination in patients with DVT.
Click –https://www.marketsandata.com/industry-reports/japan-vascular-access-devices-market
Rising Geriatric Population and Prevalence of Chronic Conditions Driving Market Growth
Japan has one of the highest proportions of elderly individuals globally, with more than 29% of its population aged 65 or older. This aging demographic is more susceptible to chronic diseases such as cardiovascular disorders, diabetes, and cancer, which often require repeated intravenous treatments, thereby boosting the demand for vascular access devices. The increase in long-term hospital stays and the need for regular drug or fluid administration further propel the market. Additionally, age-related complications increase the likelihood of conditions like kidney failure, which often require dialysis through central vascular access. These factors collectively support the growing adoption of vascular access devices in Japan’s healthcare system. For instance, according to Japan’s Ministry of Internal Affairs and Communications, as of 2023, seniors (65+) made up 29.1% of the total population, highlighting the pressing need for chronic disease management solutions.
Technological Advancements and Focus on Infection Control in Hospitals Fueling Growth
Japanese healthcare facilities are placing greater emphasis on adopting technologically advanced vascular access devices that minimize infection risk and improve efficiency. Innovations in catheter coatings, antimicrobial materials, and securement devices have significantly reduced complications such as catheter-related bloodstream infections (CRBSIs). Japan’s hospitals, known for their high standards of care and patient safety, are actively integrating smart vascular access technologies, such as ultrasound-guided placement and needle-free connectors, to enhance clinical outcomes. Moreover, post-pandemic hygiene awareness has accelerated the shift toward disposable and safer vascular access solutions. These trends are boosting the penetration of vascular access devices in both public and private healthcare settings. For example, in April 2024, Nipro partnered with Haselmeier to introduce the PiccoJect, a patient-centric autoinjector designed for 1 mL long and 2.25 mL, pre-filled syringes. The device was showcased at CPHI Japan in Tokyo, which marks Nipro’s commitment to innovative drug delivery solutions.
Increasing Demand for Peripheral Vascular Access Devices for Short-Term Use
Peripheral vascular access devices are witnessing a significant rise in adoption across Japan due to their widespread use in short-term therapies such as drug infusions, fluid administration, and nutritional support. These devices, including peripheral intravenous (PIV) catheters, are easy to insert, cost-effective, and less invasive compared to central vascular access devices, making them ideal for outpatient departments, emergency care, and routine medical interventions. The increasing number of outpatient surgeries, homecare treatments, and emergency admissions in Japan’s aging healthcare infrastructure is supporting the demand for these products. Additionally, patient preference for minimally invasive and shorter treatment durations aligns with the utility of peripheral devices. Healthcare providers in Japan are also investing in newer-generation safety-engineered PIV catheters that minimize needlestick injuries and infection risks, enhancing procedural outcomes and staff safety. These developments are collectively contributing to the growing adoption of peripheral vascular access devices in Japan’s evolving clinical care landscape. In March 2024, B. Braun Aesculap Japan introduced “Introcan Safety® 2 IV Catheter,” which features enhanced safety mechanisms to reduce needlestick injuries and is tailored for peripheral access in short-term treatments.
Future Market Scenario (FY2026 – FY2033F)
The Japan vascular access devices market is poised for steady growth in the coming years, driven by an aging population, rising chronic disease burden, and an evolving healthcare system that emphasizes minimally invasive treatments. As hospitals and clinics increasingly adopt advanced vascular access technologies to reduce infection risks and improve patient outcomes, demand for both central and peripheral access devices is expected to rise. The market is also likely to benefit from local innovation, government support for digital healthcare, and a growing preference for home-based care. Continuous R&D and product upgrades will further enhance market penetration across urban and rural settings.
Report Scope
“Japan Vascular Access Devices Market Assessment, Opportunities, and Forecast, FY2019-FY2033F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of the Japan vascular access devices market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecast between FY2026 and FY2033. Additionally, the report profiles the leading players in the industry, mentioning their respective market share, business models, competitive intelligence, etc.
Latest reports-
https://www.marketsandata.com/industry-reports/united-states-golf-shoes-market
https://www.marketsandata.com/industry-reports/aircraft-component-market
Contact
Mr. Vivek Gupta
5741 Cleveland street,
Suite 120, VA beach, VA, USA 23462
Tel: +1 (757) 343–3258
Email: info@marketsandata.com
Website: https://www.marketsandata.com
Comments
0 comment